RO7790121 Clinical Trials (2026): 1 Studies for MASH
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 RO7790121 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including MASH) and 50 total planned enrollment. Most recent activity: NCT06903065 (Dec 2026).
RO7790121 clinical trials at a glance: phase × recruitment status
| Phase | active not recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
All RO7790121 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06903065 | A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis | P1 | active not recruiting | 50 | Hoffmann-La Roche | Apr 2025 |
RO7790121 clinical trials: frequently asked questions
- How many RO7790121 clinical trials are there?
- 1 RO7790121 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are RO7790121 clinical trials recruiting in 2026?
- No active RO7790121 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is RO7790121 being studied for?
- RO7790121 is being studied for MASH. The trials are grouped by indication on this page.
- What phase is RO7790121 in?
- RO7790121 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors RO7790121 clinical trials?
- The lead sponsor across the most RO7790121 trials is Hoffmann-La Roche. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming RO7790121as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: